Results 241 to 250 of about 7,139,275 (308)

Editorial: Innovations in development, translational research and manufacturing of CAR T cells. [PDF]

Front Immunol
Krones D, Koehl U, Negre H, Rafiq Q, Goldrick S, Hudecek M.   +5 more
europepmc   +1 more source

Generation of TCRγδ + T cells from human embryonic stem cells. [PDF]

Sci Rep
Zhang X, Chen C, Fu Y, Wu H, Wang N, Shi X, Zhou Y, Duan Y.   +7 more
europepmc   +1 more source

Protocol for isolating viable human central nervous system T cells. [PDF]

STAR Protoc
Engelenburg HJ, Smolders J, Huitinga I, Hamann J, Hsiao CC.   +4 more
europepmc   +1 more source

Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells. [PDF]

Cell
Rathore U, Dugan E, Thornton H, Kumar VE, Dajani R, Burdick RC, Young JM, Steinhart Z, Lao R, Delviks-Frankenberry KA, Choi W, Henriques WS, Echeverria I, Dann E, Dureja I, Pathak N, Arce MM, McKetney J, Umhoefer JM, Parulekar S, Schmidt R, Polacco BJ, Neidleman J, Montano M, Nguyen VQ, Sali A, Levy JA, Tenthorey JL, Cheng Y, Roan NR, Swaney DL, Kaake RM, Dodgson SE, Hiatt J, Pathak VK, Malik HS, Krogan NJ, Marson A.   +37 more
europepmc   +1 more source

Role play of regulatory T cells and resolvins in type 2 diabetes. [PDF]

Front Immunol
Krishnan S, Mahadevan S, Sharma HP, Das UN, Kuppan K.   +4 more
europepmc   +1 more source

Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA. [PDF]

Nat Commun
Johnson LA, Saito K, Pallerla AV, Funnell JL, Ezzo AR, Song CM, Harrison DA, Norton NJ, Moore LC, Van Eldik LJ, Fardo DW, Cooper GE, Morganti JM.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CAR T Cells

2020
In 1891, Dr. William B. Coley, an American surgeon, made a compelling observation that immune system can be triggered to shrink tumors. The quest to exploit the power of immunotherapy however was forestalled by an era of chemotherapy that ensued.
Ranjit, Nair, Jason, Westin
openaire   +3 more sources

T-cell therapies for T-cell lymphoma

Cytotherapy, 2019
T-cell lymphomas represent a subpopulation of non-Hodgkin lymphomas with poor outcomes when treated with conventional chemotherapy. A variety of novel agents have been introduced as new treatment strategies either as first-line treatment or in conjunction with chemotherapy. Immunotherapy has been demonstrated to be a promising area for new therapeutics,
Keri Toner, Catherine M. Bollard, Hema Dave   +2 more
openaire   +2 more sources